01 8Zoladex
02 2Zoladex
Main Therapeutic Indication : Oncology
Currency : USD
2020 Revenue in Millions : 888
2019 Revenue in Millions : 813
Growth (%) : 9
Main Therapeutic Indication : Oncology
Currency : USD
2021 Revenue in Millions : 948
2020 Revenue in Millions : 888
Growth (%) : 7
Main Therapeutic Indication : Oncology
Currency : USD
2022 Revenue in Millions : 927
2021 Revenue in Millions : 948
Growth (%) : -2
Main Therapeutic Indication : Oncology
Currency : USD
2023 Revenue in Millions : 952
2022 Revenue in Millions : 927
Growth (%) : 3
Main Therapeutic Indication : Oncology
Currency : USD
2015 Revenue in Millions : 924
2014 Revenue in Millions : 816
Growth (%) : -12%
Main Therapeutic Indication : Oncology
Currency : USD
2017 Revenue in Millions : 735
2016 Revenue in Millions : 816
Growth (%) : -10
Main Therapeutic Indication : Oncology
Currency : USD
2014 Revenue in Millions : -7.20%
2013 Revenue in Millions :
Growth (%) :
Main Therapeutic Indication : Oncology
Currency : USD
2018 Revenue in Millions : 752
2017 Revenue in Millions : 735
Growth (%) : 2%
Main Therapeutic Indication : Oncology
Currency : USD
2016 Revenue in Millions : 816
2015 Revenue in Millions : 816
Growth (%) : 0
Main Therapeutic Indication : Oncology
Currency : USD
2019 Revenue in Millions : 813
2018 Revenue in Millions : 752
Growth (%) : 8
LOOKING FOR A SUPPLIER?
